Trials / Completed
CompletedNCT02540265
Placebo-Controlled Evaluation of N1539 Following Bunionectomy Surgery
A Phase 2, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Evaluation of the Safety, Efficacy, and Pharmacokinetics of N1539 Following Bunionectomy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- Baudax Bio · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate the safety of N1539 in subjects with acute moderate to severe pain following unilateral bunionectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | N1539 | |
| DRUG | Intravenous Placebo |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2015-11-01
- Completion
- 2015-11-01
- First posted
- 2015-09-03
- Last updated
- 2017-06-14
- Results posted
- 2017-06-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02540265. Inclusion in this directory is not an endorsement.